InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,652.00
(
0.06%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,724.81
(
-0.12%
)
Post# of 648882
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Tuff-Stuff

Send PM Follow Ignore
Followers 219
Posts 247348
Boards Moderated 2
Alias Born 04/06/2006

Tuff-Stuff

Re: None

Monday, 07/24/2017 6:39:18 AM

Monday, July 24, 2017 6:39:18 AM

Post# of 648882
NeuroDerm (NASDAQ:NDRM) +14.7% premarket after agreeing to be acquired by Japan's Mitsubishi Tanabe Pharma (OTCPK:MTZPY) for $39/share, a 17% premium over Friday's closing price and implying a ~$1.1B equity value.

The deal is the largest ever acquisition of an Israeli pharmaceuticals company.

The Japanese drugmaker says it will leverage NDRM's Parkinson's disease drug product that has begun clinical trials in the U.S. and Europe.

Pray for A Pain Free Day!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up